Xellar Biosystems
PrivateLast Round
Strategic
Apr 30, 2025
Total Funding Raised
$24M
Company Overview
Xellar Biosystems is a biotechnology company that provides an artificial intelligence and organ-on-a-chip platform to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xellar Biosystems Comps
Public and private peers based on sector, stage, and business model.
Xellar Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 30, 2025 | ||||
| Series A | Jul 17, 2024 | ||||
| Angel | Aug 30, 2022 |
Xellar Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ZhenFund | Angel |
| Tiantu Capital | Strategic |
| Legend Capital | Angel |
Xellar Biosystems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xellar Biosystems's valuation, stock price, and market status.
